- Home
- VUZI vs RNAC Comparison
VUZI vs RNAC Comparison
Compare VUZI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VUZI
- RNAC
- Stock Information
- Founded
- VUZI 1997
- RNAC 2007
- Country
- VUZI United States
- RNAC United States
- Employees
- VUZI N/A
- RNAC N/A
- Industry
- VUZI Industrial Machinery/Components
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- VUZI Technology
- RNAC Health Care
- Exchange
- VUZI Nasdaq
- RNAC Nasdaq
- Market Cap
- VUZI 236.4M
- RNAC 242.4M
- IPO Year
- VUZI N/A
- RNAC 2016
- Fundamental
- Price
- VUZI $2.76
- RNAC $11.21
- Analyst Decision
- VUZI Strong Buy
- RNAC Strong Buy
- Analyst Count
- VUZI 1
- RNAC 4
- Target Price
- VUZI $2.00
- RNAC $40.67
- AVG Volume (30 Days)
- VUZI 2.0M
- RNAC 69.2K
- Earning Date
- VUZI 08-13-2025
- RNAC 08-07-2025
- Dividend Yield
- VUZI N/A
- RNAC N/A
- EPS Growth
- VUZI N/A
- RNAC N/A
- EPS
- VUZI N/A
- RNAC N/A
- Revenue
- VUZI $5,331,630.00
- RNAC $34,173,000.00
- Revenue This Year
- VUZI $45.35
- RNAC N/A
- Revenue Next Year
- VUZI $54.01
- RNAC N/A
- P/E Ratio
- VUZI N/A
- RNAC N/A
- Revenue Growth
- VUZI N/A
- RNAC 31.91
- 52 Week Low
- VUZI $0.83
- RNAC $8.46
- 52 Week High
- VUZI $5.79
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- VUZI 51.22
- RNAC 59.21
- Support Level
- VUZI $2.67
- RNAC $10.01
- Resistance Level
- VUZI $2.92
- RNAC $11.75
- Average True Range (ATR)
- VUZI 0.19
- RNAC 0.71
- MACD
- VUZI -0.04
- RNAC 0.16
- Stochastic Oscillator
- VUZI 29.84
- RNAC 89.44
About VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.